DRRX
Price
$1.91
Change
-$0.02 (-1.04%)
Updated
Sep 10 closing price
Capitalization
59.31M
Intraday Buy/Sell Signals
UTHR
Price
$433.34
Change
+$0.65 (+0.15%)
Updated
Oct 17 closing price
Capitalization
19.6B
11 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

DRRX vs UTHR

Header iconDRRX vs UTHR Comparison
Open Charts DRRX vs UTHRBanner chart's image
DURECT
Price$1.91
Change-$0.02 (-1.04%)
Volume$2.79M
Capitalization59.31M
United Therapeutics
Price$433.34
Change+$0.65 (+0.15%)
Volume$524.68K
Capitalization19.6B
DRRX vs UTHR Comparison Chart in %
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRRX vs. UTHR commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRRX is a Hold and UTHR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (DRRX: $1.91 vs. UTHR: $433.34)
Brand notoriety: DRRX and UTHR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: DRRX: 146% vs. UTHR: 63%
Market capitalization -- DRRX: $59.31M vs. UTHR: $19.6B
DRRX [@Pharmaceuticals: Generic] is valued at $59.31M. UTHR’s [@Pharmaceuticals: Generic] market capitalization is $19.6B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRRX’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • DRRX’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than DRRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRRX’s TA Score shows that 3 TA indicator(s) are bullish while UTHR’s TA Score has 4 bullish TA indicator(s).

  • DRRX’s TA Score: 3 bullish, 2 bearish.
  • UTHR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DRRX is a better buy in the short-term than UTHR.

Price Growth

DRRX (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while UTHR (@Pharmaceuticals: Generic) price change was -1.51% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Reported Earning Dates

UTHR is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($19.6B) has a higher market cap than DRRX($59.3M). DRRX YTD gains are higher at: 154.667 vs. UTHR (22.815). UTHR has higher annual earnings (EBITDA): 1.73B vs. DRRX (-15.23M). UTHR has more cash in the bank: 3.05B vs. DRRX (6.5M). DRRX has less debt than UTHR: DRRX (1.75M) vs UTHR (200M). UTHR has higher revenues than DRRX: UTHR (3.08B) vs DRRX (1.66M).
DRRXUTHRDRRX / UTHR
Capitalization59.3M19.6B0%
EBITDA-15.23M1.73B-1%
Gain YTD154.66722.815678%
P/E RatioN/A16.91-
Revenue1.66M3.08B0%
Total Cash6.5M3.05B0%
Total Debt1.75M200M1%
FUNDAMENTALS RATINGS
DRRX vs UTHR: Fundamental Ratings
DRRX
UTHR
OUTLOOK RATING
1..100
5078
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10016
SMR RATING
1..100
9947
PRICE GROWTH RATING
1..100
3541
P/E GROWTH RATING
1..100
10044
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DRRX's Valuation (68) in the Pharmaceuticals Other industry is in the same range as UTHR (72). This means that DRRX’s stock grew similarly to UTHR’s over the last 12 months.

UTHR's Profit vs Risk Rating (16) in the Pharmaceuticals Other industry is significantly better than the same rating for DRRX (100). This means that UTHR’s stock grew significantly faster than DRRX’s over the last 12 months.

UTHR's SMR Rating (47) in the Pharmaceuticals Other industry is somewhat better than the same rating for DRRX (99). This means that UTHR’s stock grew somewhat faster than DRRX’s over the last 12 months.

DRRX's Price Growth Rating (35) in the Pharmaceuticals Other industry is in the same range as UTHR (41). This means that DRRX’s stock grew similarly to UTHR’s over the last 12 months.

UTHR's P/E Growth Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for DRRX (100). This means that UTHR’s stock grew somewhat faster than DRRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DRRXUTHR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
57%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
69%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
59%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDG122.580.72
+0.59%
American Century Foc Dynmc Gr ETF
DIVI37.770.11
+0.29%
Franklin Intl Core Div Tlt Idx ETF
ENJ21.93N/A
N/A
Entergy New Orleans LLC
RHTX18.12-0.04
-0.23%
RH Tactical Outlook ETF
AFK24.34-0.44
-1.78%
VanEck Africa ETF

DRRX and

Correlation & Price change

A.I.dvisor tells us that DRRX and UPC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRRX and UPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
N/A
UPC - DRRX
27%
Poorly correlated
-4.04%
BHC - DRRX
26%
Poorly correlated
+0.67%
ASRT - DRRX
25%
Poorly correlated
-2.90%
SNDL - DRRX
24%
Poorly correlated
-2.10%
INDV - DRRX
24%
Poorly correlated
-0.85%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DRRX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DRRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+0.15%
DRRX - UTHR
55%
Loosely correlated
N/A
MNKD - UTHR
38%
Loosely correlated
+2.24%
GERN - UTHR
37%
Loosely correlated
-2.44%
DAWN - UTHR
37%
Loosely correlated
-3.61%
ALNY - UTHR
36%
Loosely correlated
+0.12%
More